Dejan Radenkovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dejan Radenkovic has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
Adnan Alsourani
General Surgery Department Hospital General Universitario Gregorio Marañón Madrid Spain
1 shared publicationAlain Sauvanet
Department of HPB Surgery, AP‐HP, Hôpital Beaujon University of Paris Clichy France
1 shared publicationAlberto Balduzzi
Unit of Pancreatic Surgery University of Verona Hospital Trust Verona Italy
1 shared publication- Aleksandar Karamarkovic
Zvezdara University Clinical Center, “Nikola Spasić” Surgical Clinic, Faculty of Medicine, University of Belgrade, Dimitrija Tucovica 161, 11000 Belgrade, Serbia
1 shared publication Alice Cattelani
Unit of Pancreatic Surgery University of Verona Hospital Trust Verona Italy
1 shared publicationAlice Clarkson
Pancreatic Cancer UK London UK
1 shared publication
Latest Publications
- Open Access
- 13 July 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (3)
The European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer: Methodological Protocol
Background: Pancreatic cancer remains one of the most lethal cancers despite extensive efforts and research conducted over the past decades. To effectuate groundbreaking improvements in pancreatic cancer treatment, interdisciplinary and international collaboration is essential. Evidence‐based guidelines, including state‐of‐the‐art evidence and expert opinion, are crucial to guide medical specialists, researchers, and patients, especially on issues where consensus is still lacking. This article describes the methodological protocol for the development of the European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer. The guideline aims to identify current knowledge gaps on pancreatic cancer management, develop questions based on these knowledge gaps, and answer these questions with evidence‐based recommendations supplemented, when evidence is lacking, with expert advice for treatment and future research. Methods: This guideline development protocol is developed according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. The process is structured into six stages: First, 13 theme‐based multidisciplinary working groups are established, comprising representatives from 30 European medical and patient societies. Second, these working groups identify the most relevant current knowledge gaps on pancreatic cancer within their theme and formulate key questions. Third, the available evidence to answer these key questions is obtained through systematic reviews and the certainty of evidence is assessed using the GRADE approach. Fourth, recommendations are developed based on the available evidence. Fifth, all participants reach consensus on the recommendations through a modified Delphi process. Sixth, the recommendations are discussed during an open conference, including an external validation committee. Discussion: This methodological protocol of the European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer is designed to identify key knowledge gaps across 13 themes and formulate evidence‐based recommendations. This guideline initiative unites 30 European medical and patient societies for pancreatic cancer.
- 13 July 2026
- Published by Wiley in Clinical and Public Health Guidelines
- Vol. 3 (3)
Open AccessThe European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer: Methodological Protocol
Background: Pancreatic cancer remains one of the most lethal cancers despite extensive efforts and research conducted over the past decades. To effectuate groundbreaking improvements in pancreatic cancer treatment, interdisciplinary and international collaboration is essential. Evidence‐based guidelines, including state‐of‐the‐art evidence and expert opinion, are crucial to guide medical specialists, researchers, and patients, especially on issues where consensus is still lacking. This article describes the methodological protocol for the development of the European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer. The guideline aims to identify current knowledge gaps on pancreatic cancer management, develop questions based on these knowledge gaps, and answer these questions with evidence‐based recommendations supplemented, when evidence is lacking, with expert advice for treatment and future research. Methods: This guideline development protocol is developed according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. The process is structured into six stages: First, 13 theme‐based multidisciplinary working groups are established, comprising representatives from 30 European medical and patient societies. Second, these working groups identify the most relevant current knowledge gaps on pancreatic cancer within their theme and formulate key questions. Third, the available evidence to answer these key questions is obtained through systematic reviews and the certainty of evidence is assessed using the GRADE approach. Fourth, recommendations are developed based on the available evidence. Fifth, all participants reach consensus on the recommendations through a modified Delphi process. Sixth, the recommendations are discussed during an open conference, including an external validation committee. Discussion: This methodological protocol of the European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer is designed to identify key knowledge gaps across 13 themes and formulate evidence‐based recommendations. This guideline initiative unites 30 European medical and patient societies for pancreatic cancer.
- Open Access
- 22 September 2025
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 30 (3) , 63-69
A Review of Introductal Papillary Mucinous Neoplasia Classification, Surgical Indications, and Outcomes
Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cystic lesions with malignant potential. This review outlines current guidelines, surgical indications, outcomes, and surveillance strategies. It also highlights recent advances in minimally invasive surgery and emerging biomarkers aimed at improving risk stratification and reducing unnecessary resections.
- 22 September 2025
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 30 (3) , 63-69
Open AccessA Review of Introductal Papillary Mucinous Neoplasia Classification, Surgical Indications, and Outcomes
Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cystic lesions with malignant potential. This review outlines current guidelines, surgical indications, outcomes, and surveillance strategies. It also highlights recent advances in minimally invasive surgery and emerging biomarkers aimed at improving risk stratification and reducing unnecessary resections.
- Open Access
- 1 January 2013
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 141 (1-2) , 95-99
Spontaneous rupture of giant liver hemangioma: Case report
Introduction. Hemangioma is the most frequent benign solid tumor of the liver. It is well known that a giant liver hemangioma carries the risk of spontaneous rupture, followed by hemoperitoneum and hemorrhagic shock with possible fatal outcome. Case Outline. This is a case report of the spontaneous rupture of a giant cavernous hemangioma of the liver in an 85-year old patient. The patient was presented with abdominal pain and hemorrhagic shock. Emergency ultrasonography and computed tomography of the abdomen showed a heterogeneous ruptured solid tumor of the right liver lobe, multiple cysts in the left lobe and massive hemoperitoneum. The patient was successfully managed by immediate exploratory laparotomy, surgical enucleation of the hemangioma under intermittent inflow vascular occlusion, temporary perihepatic packing and planned second look relaparotomy. Conclusion. Immediate surgical procedure is indicated mandatory in unstable patients with a ruptured giant hemangioma of the liver. Surgical enucleation under intermittent inflow vascular occlusion and temporary perihepatic packing could be a life-saving procedure in those patients.
- 1 January 2013
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 141 (1-2) , 95-99
Open AccessSpontaneous rupture of giant liver hemangioma: Case report
Introduction. Hemangioma is the most frequent benign solid tumor of the liver. It is well known that a giant liver hemangioma carries the risk of spontaneous rupture, followed by hemoperitoneum and hemorrhagic shock with possible fatal outcome. Case Outline. This is a case report of the spontaneous rupture of a giant cavernous hemangioma of the liver in an 85-year old patient. The patient was presented with abdominal pain and hemorrhagic shock. Emergency ultrasonography and computed tomography of the abdomen showed a heterogeneous ruptured solid tumor of the right liver lobe, multiple cysts in the left lobe and massive hemoperitoneum. The patient was successfully managed by immediate exploratory laparotomy, surgical enucleation of the hemangioma under intermittent inflow vascular occlusion, temporary perihepatic packing and planned second look relaparotomy. Conclusion. Immediate surgical procedure is indicated mandatory in unstable patients with a ruptured giant hemangioma of the liver. Surgical enucleation under intermittent inflow vascular occlusion and temporary perihepatic packing could be a life-saving procedure in those patients.